Investor Presentation

Here's a summary of Fabtech Technologies Limited's investor presentation, focusing on key highlights for retail investors: **Business Performance:** Fabtech reported strong revenue growth, with Total Income up 28.4% YoY to ₹431.33 Cr.

The Middle East and Africa (MEA) region continues to be a key driver, with the UAE emerging as the largest market contributing ₹126.66 Cr, followed by KSA at ₹82.72 Cr.

Kenya also showed exceptional growth, with revenue surging 236% YoY to ₹43.42 Cr. **Growth Drivers or Strategy:** The company's integrated turnkey model, combining in-house manufacturing with expertise in Process, Air & Water systems, is a core strength.

This allows for single accountability, reduced coordination risk, and faster speed to market for pharmaceutical and healthcare projects.

Expansion into high-growth sectors like animal health and vaccines is a strategic focus. **Recent Developments:** Fabtech secured significant projects, including an animal vaccine project in Saudi Arabia and a veterinary facility in North Africa, marking an entry into the growing animal health segment. **Key Financial Metrics:** Consolidated Total Income grew 28.4% YoY to ₹431.33 Cr.

EBITDA increased by 18.29% to ₹55.56 Cr, and Operational PAT rose by 17.4% to ₹36.6 Cr.

Cash and Bank Balances saw a substantial jump of 495.7% to ₹208.57 Cr.

Total Equity grew by 142.5% to ₹419.77 Cr. **Management Commentary / Outlook:** Fabtech has a robust order book of over ₹900 Cr, providing strong revenue visibility.

The company has a positive growth outlook driven by its strong order pipeline, ongoing geographic expansion, and focus on complex, high-value projects.

They have successfully navigated global volatilities, demonstrating operational resilience.